Evidence map›Paper›PMID 42163855›Full record

ArticleACS applied nano materials2026

Evaluating NIR-II-Emissive Graphene Quantum Dot Biodistribution, Toxicity, and Clearance for

Alina Valimukhametova, Natalia Castro-Lopez, Pramita Sharma, Kseniia Malkova, Ali Gasimli, Ugur Can Topkiran, Himish Paul, Diya Vashani, Olga Zub, Floyd L Wormley and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied nano materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alina ValimukhametovaDepartment of Physics and Astronomy, Texas Christian University, Fort Worth, Texas 76109, United States.
Natalia Castro-LopezDepartment of Biology, Texas Christian University, Fort Worth, Texas 76109, United States.
Pramita SharmaDepartment of Physics and Astronomy, Texas Christian University, Fort Worth, Texas 76109, United States.ORCID https://orcid.org/0000-0003-0071-9843
Kseniia MalkovaDepartment of Pathology, The University of Texas Medical Branch, Galveston, Texas 77555, Unites States.
Ali GasimliDepartment of Physics and Astronomy, Texas Christian University, Fort Worth, Texas 76109, United States.
Ugur Can TopkiranDepartment of Physics and Astronomy, Texas Christian University, Fort Worth, Texas 76109, United States.ORCID https://orcid.org/0000-0001-5345-7782
Himish PaulDepartment of Physics and Astronomy, Texas Christian University, Fort Worth, Texas 76109, United States.
Diya VashaniDepartment of Physics and Astronomy, Texas Christian University, Fort Worth, Texas 76109, United States.
Olga ZubAlfa Radiology Management, Inc, Plano, Texas 75023, United States.
Floyd L WormleyDepartment of Biology, Texas Christian University, Fort Worth, Texas 76109, United States.
Anton V NaumovDepartment of Physics and Astronomy, Texas Christian University, Fort Worth, Texas 76109, United States.ORCID https://orcid.org/0000-0001-6427-7277

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Near-infrared-II (NIR-II) fluorescence has emerged as a promising modality for biomedical imaging due to its ability to overcome the limitations of autofluorescence, scattering, and absorption inherent to shorter wavelengths. Nanoscale drug delivery platforms can strongly benefit from such imaging capabilities, facilitating noninvasive therapeutic tracking and diagnostics through the layers of biological tissue. Among nanomaterials, graphene quantum dots (GQDs) show the most potential in intrinsic NIR-II fluorescence imaging due to their photostability, biocompatibility, and low-cost/straightforward synthesis. This study for the first time evaluates all essential

Indexed as

biodistribution studyex vivo imaginggraphene quantum dotsin vivo imagingNIR-II fluorescence

Identifiers

PMID42163855
PMCPMC13184933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.